872PPhase Ib study (COSMIC-021) of cabozantinib in combination with atezolizumab: Results of the dose escalation stage in patients (pts) with treatment-naïve advanced renal cell carcinoma (RCC).
Saved in:
| Title: | 872PPhase Ib study (COSMIC-021) of cabozantinib in combination with atezolizumab: Results of the dose escalation stage in patients (pts) with treatment-naïve advanced renal cell carcinoma (RCC). |
|---|---|
| Authors: | Agarwal, N1 (AUTHOR), Vaishampayan, U2 (AUTHOR), Green, M3 (AUTHOR), Nucci, F di3 (AUTHOR), Chang, P-Y4 (AUTHOR), Scheffold, C4 (AUTHOR), Pal, S5 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdy283.081 |
